Skip to main content

Published locations for Medicare patients’ cost burden for specialty psoriasis, PsA drugs remains high

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Medicare patients’ cost burden for specialty psoriasis, PsA drugs remains high

User login

  • Reset your password
  • /content/medicare-patients-cost-burden-specialty-psoriasis-psa-drugs-remains-high
  • /edermatologynews/article/246125/psoriasis/medicare-patients-cost-burden-specialty-psoriasis-psa
  • /familypracticenews/article/246125/psoriasis/medicare-patients-cost-burden-specialty-psoriasis-psa
  • /internalmedicinenews/article/246125/psoriasis/medicare-patients-cost-burden-specialty-psoriasis-psa
  • /rheumatologynews/article/246125/psoriasis/medicare-patients-cost-burden-specialty-psoriasis-psa
  • /rheumatology/article/246125/psoriasis/medicare-patients-cost-burden-specialty-psoriasis-psa-drugs
  • /internalmedicine/article/246125/psoriasis/medicare-patients-cost-burden-specialty-psoriasis-psa
  • /dermatology/article/246125/psoriasis/medicare-patients-cost-burden-specialty-psoriasis-psa-drugs
  • /familymedicine/article/246125/psoriasis/medicare-patients-cost-burden-specialty-psoriasis-psa-drugs
  • /rheumatology/psoriatic-arthritis-resource-center/article/246125/psoriasis/medicare-patients-cost
  • /dermatology/psoriasiscollection/article/246125/psoriasis/medicare-patients-cost-burden-specialty
  • /psoriatic-arthritis-icymi/article/246125/psoriasis/medicare-patients-cost-burden-specialty-psoriasis